These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 24339446)
21. Fluorine-NMR experiments for high-throughput screening: theoretical aspects, practical considerations, and range of applicability. Dalvit C; Fagerness PE; Hadden DT; Sarver RW; Stockman BJ J Am Chem Soc; 2003 Jun; 125(25):7696-703. PubMed ID: 12812511 [TBL] [Abstract][Full Text] [Related]
22. Combination of cell-free expression and NMR spectroscopy as a new approach for structural investigation of membrane proteins. Koglin A; Klammt C; Trbovic N; Schwarz D; Schneider B; Schäfer B; Löhr F; Bernhard F; Dötsch V Magn Reson Chem; 2006 Jul; 44 Spec No():S17-23. PubMed ID: 16826540 [TBL] [Abstract][Full Text] [Related]
23. Applicability of a blood-brain barrier specific artificial membrane permeability assay at the early stage of natural product-based CNS drug discovery. Könczöl A; Müller J; Földes E; Béni Z; Végh K; Kéry A; Balogh GT J Nat Prod; 2013 Apr; 76(4):655-63. PubMed ID: 23565574 [TBL] [Abstract][Full Text] [Related]
24. Design and generation of highly diverse fluorinated fragment libraries and their efficient screening with improved (19) F NMR methodology. Vulpetti A; Dalvit C ChemMedChem; 2013 Dec; 8(12):2057-69. PubMed ID: 24127294 [TBL] [Abstract][Full Text] [Related]
25. Current NMR Techniques for Structure-Based Drug Discovery. Sugiki T; Furuita K; Fujiwara T; Kojima C Molecules; 2018 Jan; 23(1):. PubMed ID: 29329228 [TBL] [Abstract][Full Text] [Related]
26. Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects. Dalvit C; Vulpetti A J Med Chem; 2019 Mar; 62(5):2218-2244. PubMed ID: 30295487 [TBL] [Abstract][Full Text] [Related]
27. Ring current shifts in (19)F-NMR of membrane proteins. Liu D; Wüthrich K J Biomol NMR; 2016 May; 65(1):1-5. PubMed ID: 27240587 [TBL] [Abstract][Full Text] [Related]
28. Fluorine detected 2D NMR experiments for the practical determination of size and sign of homonuclear F-F and heteronuclear C-F multiple bond J-coupling constants in multiple fluorinated compounds. Aspers RL; Ampt KA; Dvortsak P; Jaeger M; Wijmenga SS J Magn Reson; 2013 Jun; 231():79-89. PubMed ID: 23603575 [TBL] [Abstract][Full Text] [Related]
29. Simultaneous (19)F NMR screening of prolyl oligopeptidase and dipeptidyl peptidase IV inhibitors. Kichik N; Tarragó T; Giralt E Chembiochem; 2010 May; 11(8):1115-9. PubMed ID: 20397181 [TBL] [Abstract][Full Text] [Related]
30. [NMR in the fragment-based drug discovery]. Hanzawa H; Takizawa T Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1617-21. PubMed ID: 21089597 [No Abstract] [Full Text] [Related]
31. Solid-state NMR spectroscopy on complex biomolecules. Renault M; Cukkemane A; Baldus M Angew Chem Int Ed Engl; 2010 Nov; 49(45):8346-57. PubMed ID: 20941715 [TBL] [Abstract][Full Text] [Related]
32. Fluorine-19 NMR of integral membrane proteins illustrated with studies of GPCRs. Didenko T; Liu JJ; Horst R; Stevens RC; Wüthrich K Curr Opin Struct Biol; 2013 Oct; 23(5):740-747. PubMed ID: 23932201 [TBL] [Abstract][Full Text] [Related]
33. Determination of the oligomeric number and intermolecular distances of membrane protein assemblies by anisotropic 1H-driven spin diffusion NMR spectroscopy. Luo W; Hong M J Am Chem Soc; 2006 Jun; 128(22):7242-51. PubMed ID: 16734478 [TBL] [Abstract][Full Text] [Related]
34. RAMPED-UP NMR: multiplexed NMR-based screening for drug discovery. Zartler ER; Hanson J; Jones BE; Kline AD; Martin G; Mo H; Shapiro MJ; Wang R; Wu H; Yan J J Am Chem Soc; 2003 Sep; 125(36):10941-6. PubMed ID: 12952475 [TBL] [Abstract][Full Text] [Related]
35. NMR-based screening of membrane protein ligands. Yanamala N; Dutta A; Beck B; van Fleet B; Hay K; Yazbak A; Ishima R; Doemling A; Klein-Seetharaman J Chem Biol Drug Des; 2010 Mar; 75(3):237-56. PubMed ID: 20331645 [TBL] [Abstract][Full Text] [Related]
36. High-field EPR on membrane proteins - crossing the gap to NMR. Möbius K; Lubitz W; Savitsky A Prog Nucl Magn Reson Spectrosc; 2013 Nov; 75():1-49. PubMed ID: 24160760 [TBL] [Abstract][Full Text] [Related]
37. Solid-state magic-angle spinning NMR of membrane proteins and protein-ligand interactions. Franks WT; Linden AH; Kunert B; van Rossum BJ; Oschkinat H Eur J Cell Biol; 2012 Apr; 91(4):340-8. PubMed ID: 22019511 [TBL] [Abstract][Full Text] [Related]
38. Lead Identification Through the Synergistic Action of Biomolecular NMR and In Silico Methodologies. Marousis KD; Tsika AC; Birkou M; Matsoukas MT; Spyroulias GA Methods Mol Biol; 2018; 1824():299-316. PubMed ID: 30039415 [TBL] [Abstract][Full Text] [Related]
39. Determination and identification of estrogenic compounds generated with biosynthetic enzymes using hyphenated screening assays, high resolution mass spectrometry and off-line NMR. de Vlieger JS; Kolkman AJ; Ampt KA; Commandeur JN; Vermeulen NP; Kool J; Wijmenga SS; Niessen WM; Irth H; Honing M J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):667-74. PubMed ID: 20149764 [TBL] [Abstract][Full Text] [Related]
40. Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis? Goldman RC Tuberculosis (Edinb); 2013 Nov; 93(6):569-88. PubMed ID: 24119636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]